Volume 14, Issue 2 (2-2026)                   JoMMID 2026, 14(2): 159-167 | Back to browse issues page

Ethics code: ETHICAL

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
M S, Martin S, Ameena B, Kumari B A, Radhakrishnan P. Identification, Antibiogram, and Phenotypic Detection of β-Lactamase-Mediated Resistance in Non-Fermenting Gram-Negative Bacilli (NFGNB) from a Tertiary Care Hospital in Mysore. JoMMID 2026; 14 (2) :159-167
URL: http://jommid.pasteur.ac.ir/article-1-710-en.html
Identification, Antibiogram, and Phenotypic Detection of β-Lactamase-Mediated Resistance in Non-Fermenting Gram-Negative Bacilli (NFGNB) from a Tertiary Care Hospital in Mysore
Swetha M , Sherin Martin , Beebi Ameena * , Amrutha Kumari B , Priyadharshini Radhakrishnan
Department of Microbiology, Mysore Medical College and Research Institute, Mysore, Karnataka, India
Abstract:   (11 Views)
Introduction: Non-fermenting Gram-negative bacilli (NFGNB) are emerging healthcare-associated pathogens whose rapidly escalating antimicrobial resistance poses substantial therapeutic challenges. This study aimed to determine the prevalence and antimicrobial resistance patterns of NFGNB and to detect β-lactamase-mediated resistance mechanisms (extended-spectrum β-lactamase [ESBL], metallo-β-lactamase [MBL], and AmpC) in a tertiary care hospital in Mysore, Karnataka, India. Methods: In this prospective two-month study, NFGNB were isolated from various clinical specimens (blood, pus, urine, synovial fluid, suction catheter tips, and endotracheal aspirates). Blood specimens were inoculated into brain–heart infusion broth and subcultured onto blood agar and MacConkey agar; all other specimens were plated directly and incubated aerobically at 37 °C for 16–18 h. Bacterial identification and antimicrobial susceptibility testing were performed using the BD Phoenix M50 system. Phenotypic detection of ESBL, MBL, and AmpC was carried out using combined disc-based methods, as the Clinical and Laboratory Standards Institute (CLSI) does not provide standardized confirmatory tests for these mechanisms in non-fermenters. Results: Of 3,000 clinical specimens, 50 yielded NFGNB (prevalence, 1.7%), with 64% originating from ICUs (95% CI: 49.2–77.1%). The predominant species were Pseudomonas putida (18%), Pseudomonas aeruginosa (16%), and Acinetobacter baumannii (16%). P. putida exhibited 100% resistance to ceftazidime, cefepime, ciprofloxacin, levofloxacin, piperacillin–tazobactam, tetracycline, and cefotaxime, while amikacin and gentamicin retained activity against 77.8% and 88.9% of isolates, respectively. P. aeruginosa showed high resistance to ceftazidime and cefepime (87.5% each) and to piperacillin–tazobactam and levofloxacin (75% each). A. baumannii was uniformly susceptible to colistin but resistant to most other agents. Phenotypic analysis revealed ESBL production in 28%, MBL production in 34%, and presumptive AmpC production in 92% of isolates, of which 60.9% were confirmed. Multiple β-lactamase types co-occurred in several isolates. Conclusion: The high prevalence of multidrug-resistant NFGNB, particularly extensively drug-resistant P. putida and carbapenem-resistant Acinetobacter species, underscores the urgent need for strengthened local antimicrobial resistance surveillance, timely identification, and continuous monitoring of resistance trends to guide targeted therapy and improve patient outcomes.
 
Keywords: Non-fermenting Gram-negative bacilli, Antimicrobial resistance, ESBL, MBL, AmpC, β-Lactamase, Healthcare-associated infection
Full-Text [PDF 840 kb]   (4 Downloads)    
Type of Study: Original article | Subject: Anti-microbial agents, resistance and treatment protocols
Received: 2025/02/28 | Accepted: 2026/02/21 | Published: 2026/09/7
References
1. Winn WC. Non fermenting Gram negative bacilli. In: Winn WC, Allen SD, Janda WM, Koneman EW, Procop GW, Schreckenberger PC, Woods GL, editors. Koneman's Color Atlas and Textbook of Diagnostic Microbiology. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 318.
2. Dash RK, Mohapatra I, Singh N, Pattnaik D, Panda SS, Smriti S, et al. five‑year trend analysis of antibacterial resistance patterns among non‑fermenting Gram‑negative bacilli: a retrospective study from the ICU settings of a tertiary care hospital. Cureus. 2024; 16 (9): e70375. [DOI:10.7759/cureus.70375]
3. Mahon RC, Lehman CD, George M. Non‑fermenting and miscellaneous Gram‑negative bacilli. In: Mahon RC, Lehman CD, Manos J, editors. Textbook of Diagnostic Microbiology. 3rd ed. New Delhi: Elsevier; 2006. p. 564‑77.
4. Eltahawy AT, Khalaf RM. Antibiotic resistance among Gram‑negative non‑fermentative bacteria at a teaching hospital in Saudi Arabia. J Chemother. 2001; 13 (3): 260‑4. [DOI:10.1179/joc.2001.13.3.260] [PMID]
5. Di Pilato V, Willison E, Marchese A. The microbiology and pathogenesis of non-fermenting Gram-negative infections. Curr Opin Infect Dis. 2023; 36 (6): 537-44. [DOI:10.1097/QCO.0000000000000969] [PMID] [PMCID]
6. Breidenstein EB, de la Fuente-Núñez C, Hancock RE. Pseudomonas aeruginosa: all roads lead to resistance. Trends Microbiol. 2011; 19 (8): 419-26. [DOI:10.1016/j.tim.2011.04.005] [PMID]
7. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. 32nd ed. CLSI supplement M100. Wayne (PA): Clinical and Laboratory Standards Institute; 2022.
8. Usha Rani P, Vijayalakshmi P. Detection of metallo-beta-lactamase production in rare carbapenem-resistant non-fermentative Gram-negative bacilli isolated in a tertiary care hospital, Visakhapatnam, India. J Med Microbiol Infect Dis. 2016; 4 (1): 31-6.
9. Gondha S, Kavathia G, Bhattacharya A. A study of isolation, identification and antibiotic susceptibility pattern of non-fermenting Gram-negative bacilli isolated from various clinical samples at a tertiary care hospital, Rajkot, Gujarat, Western India. Saudi J Pathol Microbiol. 2022; 7 (6): 233-9. [DOI:10.36348/sjpm.2022.v07i06.002]
10. Tan G, Xi Y, Yuan P, Sun Z, Yang D. Risk factors and antimicrobial resistance profiles of Pseudomonas putida infection in Central China, 2010-2017. Medicine (Baltimore). 2019; 98 (44): e17812. [DOI:10.1097/MD.0000000000017812] [PMID]
11. Walsh TR, Toleman MA, Poirel L, Nordmann P. Metallo-β-lactamases: the quiet before the storm? Clin Microbiol Rev. 2005; 18 (2): 306-25. [DOI:10.1128/CMR.18.2.306-325.2005] [PMID] [PMCID]
12. Adan FN, Jeele MO, Omar NM. Epidemiology of multidrug-resistant non-fermentative Gram-negative bacilli in patients with hospital-acquired pneumonia: an alarming report from Somalia. Infect Drug Resist. 2022; 15: 6297-305. [DOI:10.2147/IDR.S387370] [PMID] [PMCID]
13. Ndzabandzaba S, Mothibi L, Von Knorring N. Non-fermenter Gram-negative bacilli at a tertiary hospital, South Africa. South Afr J Infect Dis. 2023; 38 (1): a538. [DOI:10.4102/sajid.v38i1.538] [PMID] [PMCID]
14. Arora U, Aggarwal A, Sofat S. Non-fermenters in human infections. Indian J Pathol Microbiol. 2003; 46 (2): 265-7.
15. Sader HS, Jones RN. Antimicrobial susceptibility of uncommonly isolated non-enteric Gram-negative bacilli. Int J Antimicrob Agents. 2005; 25 (2): 95-109. [DOI:10.1016/j.ijantimicag.2004.10.002] [PMID]
16. Hsueh PR, Teng LJ, Lee LN, Yang PC, Ho SW, Luh KT. Nosocomial infections caused by Pseudomonas putida: clinical features and microbiological characteristics. J Clin Microbiol. 2000; 38 (12): 4506-11.
17. Lombardi G, Luzzaro F, Docquier JD, Riccio ML, Perilli M, Colì A, et al. Nosocomial infections caused by multidrug-resistant isolates of Pseudomonas putida producing VIM-1 metallo-β-lactamase. J Clin Microbiol. 2002; 40 (11): 4051-5. [DOI:10.1128/JCM.40.11.4051-4055.2002] [PMID] [PMCID]
18. Silby MW, Winstanley C, Godfrey SA, Levy SB, Jackson RW. Pseudomonas genomes: diverse and adaptable. FEMS Microbiol Rev. 2011; 35 (4): 652-80. [DOI:10.1111/j.1574-6976.2011.00269.x] [PMID]
19. Parandekar PK, Peerapur BV. Non-fermenters in human infections with special reference to Acinetobacter species in a tertiary care hospital from North Karnataka, India. J Krishna Inst Med Sci Univ. 2012; 1 (1): 84-8.
20. Norris SC, Pandya HB, Pipaliya BP, Javadekar TB. Antimicrobial resistance patterns in Acinetobacter baumannii: a study from a tertiary care center in Vadodara, Gujarat. Indian J Microbiol Res. 2024; 11 (3): 211-14. [DOI:10.18231/j.ijmr.2024.038]
21. Inamdar DP, Anuradha B. Phenotypic methods for detection of AmpC β-lactamases in Gram-negative clinical isolates of a tertiary care hospital. Indian J Microbiol Res. 2020; 7 (2): 125-9. [DOI:10.18231/j.ijmr.2020.024]
22. Wassef M, Behiry I, Younan M, El Guindy N, Mostafa S, Abada E. Genotypic identification of AmpC β-lactamase production in Gram negative bacilli isolates. Jundishapur J Microbiol. 2014; 7 (1): e8556. [DOI:10.5812/jjm.8556] [PMID] [PMCID]
23. Jacoby GA. AmpC β-lactamases. Clin Microbiol Rev. 2009;22(1):161-82. [DOI:10.1128/CMR.00036-08] [PMID]
24. Siegel JD, Rhinehart E, Jackson M, Chiarello L; Healthcare Infection Control Practices Advisory Committee. 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings. Atlanta (GA): Centers for Disease Control and Prevention; 2007. [DOI:10.1016/j.ajic.2007.10.007] [PMID]
25. Gupta R, Malik A, Rizvi M, Ahmed M. Presence of metallo β-lactamases (MBL), extended spectrum β-lactamase (ESBL) and AmpC positive non fermenting Gram negative bacilli among intensive care unit patients with special reference to molecular detection of blaCTX-M and blaAmpC genes. Indian J Med Res. 2016; 144 (2): 271-5. [DOI:10.4103/0971-5916.195043] [PMID] [PMCID]
26. Kaur A, Gill AK, Singh S. Prevalence and antibiogram of non-fermenting Gram-negative bacilli isolates obtained from various clinical samples in a tertiary care hospital, Bathinda, Punjab, India. Int J Res Med Sci. 2018; 6 (4): 1228-33. [DOI:10.18203/2320-6012.ijrms20181273]
27. Somily A, Balkhy HH, Enani MA, Althawadi SI, Alawi M, Al Johani SM, et al. Antimicrobial resistance trends of non-fermenter Gram-negative bacteria in Saudi Arabia: a six-year national study. J Infect Public Health. 2021; 14 (9): 1144-50. [DOI:10.1016/j.jiph.2021.07.007] [PMID]
28. Malini A, Deepa EK, Gokul BN, Prasad SR. Non-fermenting Gram-negative bacilli infections in a tertiary care hospital in Kolar, Karnataka. J Lab Physicians. 2009; 1 (2): 62-6. [DOI:10.4103/0974-2727.59701] [PMID] [PMCID]
29. Panwar S, Chavan SK. Prevalence and in vitro antibiogram of non-fermenting gram negative bacilli in a tertiary care hospital of Karnataka. Indian J Microbiol Res. 2020; 7 (2): 130-6.
30. Choudhury K, Kundu S, Bhunia S, Mallick T, Bhattacharjee SG, Dey JB. A study on the magnitude of non‑fermenter Gram‑negative bacilli and their antibiotic susceptibility pattern in clinical samples from a tertiary care hospital, Kolkata. J Compr Health. 2024; 12 (1): 39‑43. [DOI:10.25259/JCH_4_2023]
Add your comments about this article : Your username or Email:
CAPTCHA
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.